Vivos Therapeutics (VVOS) EBIT Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBIT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.92 Bn | 9.82 Bn | 757.43 Mn | -257.00 |
| 2 | Envista Holdings | 4.31 Bn | 3.18 Bn | 407.00 Mn | -92.00 |
| 3 | Dentsply Sirona | 2.14 Bn | 1.90 Bn | 493.00 Mn | 135.00 |
| 4 | Milestone Scientific | 37.15 Mn | 34.54 Mn | 1.56 Mn | 1,339.00 |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | - |
| 6 | Vivos Therapeutics | 3.19 Mn | 1.39 Mn | 2.95 Mn | 3,941.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,941.00 |
| Mar 31, 2026 | 109.00 |
| Dec 31, 2025 | -1,340.00 |
| Sep 30, 2025 | 5,755.00 |
| Jun 30, 2025 | 3,909.00 |
| Mar 31, 2025 | 5,228.00 |
| Dec 31, 2024 | 9,278.00 |
| Sep 30, 2024 | 5,253.00 |
| Jun 30, 2024 | 4,255.00 |
| Mar 31, 2024 | -1,192.00 |
| Dec 31, 2023 | 6,169.00 |
| Sep 30, 2023 | -5,506.00 |
| Jun 30, 2023 | -8,972.00 |
| Mar 31, 2023 | -4,975.00 |